In Setback For Mylan, Judge Upholds Levaquin Patent
Last week, U.S. District Judge Irene M. Keeley prohibited Mylan from making or selling levofloxacin tablets, a generic form of Levaquin.
The drug is used to treat a variety of conditions, including bronchitis, sinusitis and urinary tract infections.
Ortho-McNeil Pharmaceutical Inc., a Johnson & Johnson company that sells Levaquin in the U.S., and Japanese patent-owner Daiichi Pharmaceutical Co. had filed their first lawsuit in...
To view the full article, register now.